Orthopediatrics (KIDS) Cash from Financing Activities (2016 - 2026)
Orthopediatrics (KIDS) posted quarterly Cash from Financing Activities of -$614000.0 for Q1 2026, down 387.3% year-over-year from $213712.7 in Q1 2025, and down 47.24% quarter-over-quarter from -$417000.0 in Q4 2025.
Orthopediatrics (KIDS) Cash from Financing Activities (2016 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has reported Cash from Financing Activities for 11 consecutive years, with -$614000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 387.3% year-over-year to -$614000.0; the TTM figure through Mar 2026 stood at $23.5 million (down 56.17% YoY), while the FY2025 annual figure was $24.0 million, down 54.88% from the prior year.
- Cash from Financing Activities eased to -$614000.0 in Q1 2026 per KIDS's latest filing, from -$417000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $108.3 million in Q3 2022 and bottomed at -$4.3 million in Q2 2024.
- Historically, Cash from Financing Activities has averaged $12.9 million across 5 years, with a median of -$36000.0 in 2023.
- On a YoY basis, Cash from Financing Activities climbed as much as 390220.0% in 2024 and fell as far as 1491.67% in 2024.
- Orthopediatrics' Cash from Financing Activities stood at -$35000.0 in 2022, then soared by 26920.0% to $9.4 million in 2023, then tumbled by 105.76% to -$541000.0 in 2024, then advanced by 22.92% to -$417000.0 in 2025, then slumped by 47.24% to -$614000.0 in 2026.
- Business Quant data shows KIDS's Cash from Financing Activities at -$614000.0 in Q1 2026, -$417000.0 in Q4 2025, and -$282000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Orthopediatrics | 613.72 Mn | 567.84 Mn | 52.37 Mn | -737,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -737,000.00 |
| Jun 30, 2026 | -737,000.00 |
| Mar 31, 2026 | -614,000.00 |
| Mar 31, 2026 | -614,000.00 |
| Dec 31, 2025 | -417,000.00 |
| Dec 31, 2025 | -417,000.00 |
| Sep 30, 2025 | -282,000.00 |
| Sep 30, 2025 | -282,000.00 |
| Jun 30, 2025 | 24.80 Mn |
| Jun 30, 2025 | 24.80 Mn |
| Mar 31, 2025 | -126,000.00 |
| Mar 31, 2025 | -126,000.00 |
| Dec 31, 2024 | -541,000.00 |
| Dec 31, 2024 | -541,000.00 |
| Sep 30, 2024 | 58.52 Mn |
| Sep 30, 2024 | 58.52 Mn |
| Jun 30, 2024 | -4.27 Mn |
| Jun 30, 2024 | -4.27 Mn |
| Mar 31, 2024 | -573,000.00 |
| Mar 31, 2024 | -573,000.00 |